DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

被引：0
|
作者：
Dinmohamed, A. [1 ]
Visser, O. [2 ]
Posthuma, W. [3 ]
Huijgens, P. [2 ,4 ]
Sonneveld, P. [1 ]
van de Loosdrecht, A. [4 ]
Jongen-Lavrencic, M. [1 ]
机构：
[1] Erasmus MC Canc Inst, Hematol, Rotterdam, Netherlands
[2] Comprehens Canc Ctr Netherlands, Registrat & Res, Utrecht, Netherlands
[3] Reinier de Graaf Grp, Internal Med, Delft, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Hematol, Amsterdam, Netherlands
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1216
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [21] Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)
    Smith, Angela R.
    Warlick, Erica D.
    Fonstad, Rachel K.
    Roesler, Michelle A.
    Poynter, Jenny N.
    Hirsch, Betsy
    Nguyen, Phuong L.
    Cioc, Adina
    Ross, Julie A.
    BLOOD, 2013, 122 (21)
  • [22] The Population-Based 'real world' of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients
    Bowen, David
    Smith, Alex
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argyris
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo F.
    Cermak, Jaroslav
    Georgescu, Otilia
    Germing, Ulrich
    MacKenzie, Marius
    Stauder, Reinhard
    Beyne-Rauzy, Odile
    Malcovati, Luca
    de Witte, Theo
    BLOOD, 2010, 116 (21) : 778 - 778
  • [23] Treatment Outcome of Patients with Myelodysplastic Syndromes (MDS) in Regular Care: Incidence of IPSS Risk Groups and Different Therapies in the German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Isolde
    Lathan, Bernd
    Sauer, Annette
    Moorahrend, Enno
    Severin, Kai
    Germing, Ulrich
    Schmitz, Stephan
    Gattermann, Norbert
    BLOOD, 2014, 124 (21)
  • [24] Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS
    ML Amigo
    MC del Cañizo
    A Rios
    MA Garcia
    MD Caballero
    A Martin
    N Bermejo
    P Vilches
    JF San Miguel
    Bone Marrow Transplantation, 1999, 23 : 997 - 1002
  • [25] Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS
    Amigo, ML
    del Cañizo, M
    Rios, A
    Garcia, MA
    Caballero, MD
    Martin, A
    Bermejo, N
    Vilches, P
    San Miguel, JF
    BONE MARROW TRANSPLANTATION, 1999, 23 (10) : 997 - 1002
  • [26] LONG-TERM RESULTS OF THE "PROSPECTIVE STUDY OF THE DIAGNOSIS AND TREATMENT OF MYELODYSPLASTIC SYNDROMES IN CHILDHOOD (EWOG-MDS 98)"
    Strauss, A.
    Yoshimi, A.
    Baumann, I.
    Ussowicz, M.
    de Moerloose, B.
    Schlegelberger, B.
    Dworzak, M.
    Schmugge, M.
    Zecca, M.
    Fischer, A.
    Noellke, P.
    van den Heuvel-Eibrink, M. M.
    Stary, J.
    Hasle, H.
    Locatelli, F.
    Niemeyer, C.
    HAEMATOLOGICA, 2015, 100 : 1 - 1
  • [27] Azacitidine: Duration of treatment used in routine clinical practice in patients with myelodysplastic syndromes (MDS) in England
    Legg, A.
    Killick, S.
    Farrell, J.
    Le Reun, C.
    Howells, R.
    Vyas, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 79 - 79
  • [28] Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study
    Pease, Daniel
    Ross, Julie A.
    Nguyen, Phuong L.
    Hirsch, Betsy
    Cioc, Adina
    Smith, Angela R.
    Roesler, Michelle A.
    Fonstad, Rachel K.
    Warlick, Erica D.
    BLOOD, 2013, 122 (21)
  • [29] Do elderly patient suffering from myelodysplastic syndromes (MDS) have access to investigational drugs? Study of a French cohort of 82 MDS in a population-based sample 80 years and older
    Chanty, M.-P.
    LEUKEMIA RESEARCH, 2007, 31 : S108 - S108
  • [30] MDS CLEARPATH: AWEB-BASED EDUCATIONAL ALGORITHM FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS); 2023 UPDATE
    Leitch, H.
    Leber, B.
    Olney, H.
    Shamy, A.
    LEUKEMIA RESEARCH, 2023, 128
12345